Jiangsu Hengrui | 600276 - Sales Revenues

Stock Price
52.43
Daily Change
-1.56 -2.89%
Monthly
-6.94%
Yearly
-1.91%
Q2 Forecast
52.90

Jiangsu Hengrui reported CNY8.14B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Cspc Pharmaceutical CNY 6.11B 502.75M Dec/2025
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Sh Fosun Pharma CNY 10.07B 260M Dec/2026
Sh Pharmaceutical CNY 68.51B 4.97B Mar/2026
Sino Biopharmaceutical CNY 14.26B 3.31B Dec/2025
Wuxi Apptec CNY 12.6B 160M Dec/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M Mar/2026